193 related articles for article (PubMed ID: 22760901)
1. The effect of acute magnesium loading on the maximal exercise performance of stable chronic obstructive pulmonary disease patients.
Amaral AF; Gallo L; Vannucchi H; Crescêncio JC; Vianna EO; Martinez JA
Clinics (Sao Paulo); 2012; 67(6):615-22. PubMed ID: 22760901
[TBL] [Abstract][Full Text] [Related]
2. Effects of acute magnesium loading on pulmonary function of stable COPD patients.
do Amaral AF; Rodrigues-Júnior AL; Terra Filho J; Vannucchi H; Martinez JA
Med Sci Monit; 2008 Oct; 14(10):CR524-9. PubMed ID: 18830192
[TBL] [Abstract][Full Text] [Related]
3. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease.
O'Donnell DE; Voduc N; Fitzpatrick M; Webb KA
Eur Respir J; 2004 Jul; 24(1):86-94. PubMed ID: 15293609
[TBL] [Abstract][Full Text] [Related]
4. Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD.
O'Donnell DE; Sciurba F; Celli B; Mahler DA; Webb KA; Kalberg CJ; Knobil K
Chest; 2006 Sep; 130(3):647-56. PubMed ID: 16963658
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of procaterol on exercise dynamic lung hyperinflation during the 6-min walk test in stable patients with chronic obstructive pulmonary disease.
Satake M; Takahashi H; Sugawara K; Kawagoshi A; Tamaki A; Homma M; Morita R; Sato K; Sano M; Shioya T
Arzneimittelforschung; 2011; 61(1):8-13. PubMed ID: 21355441
[TBL] [Abstract][Full Text] [Related]
6. Low resting diffusion capacity, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease.
Elbehairy AF; O'Donnell CD; Abd Elhameed A; Vincent SG; Milne KM; James MD; Webb KA; Neder JA; O'Donnell DE;
J Appl Physiol (1985); 2019 Oct; 127(4):1107-1116. PubMed ID: 31369329
[TBL] [Abstract][Full Text] [Related]
7. Asymptomatic peripheral artery disease can limit maximal exercise capacity in chronic obstructive pulmonary disease patients regardless of airflow obstruction and lung hyperinflation.
Crisafulli E; Scelfo C; Tzani P; Aiello M; Bertorelli G; Chetta A
Eur J Prev Cardiol; 2017 Jun; 24(9):990-999. PubMed ID: 28436723
[TBL] [Abstract][Full Text] [Related]
8. Exercise performance and differences in physiological response to pulmonary rehabilitation in severe chronic obstructive pulmonary disease with hyperinflation.
Albuquerque AL; Quaranta M; Chakrabarti B; Aliverti A; Calverley PM
J Bras Pneumol; 2016 Apr; 42(2):121-9. PubMed ID: 27167433
[TBL] [Abstract][Full Text] [Related]
9. Breathing pattern and gas exchange at peak exercise in COPD patients with and without tidal flow limitation at rest.
Díaz O; Villafranca C; Ghezzo H; Borzone G; Leiva A; Milic-Emili J; Lisboa C
Eur Respir J; 2001 Jun; 17(6):1120-7. PubMed ID: 11491153
[TBL] [Abstract][Full Text] [Related]
10. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.
Ikeda A; Nishimura K; Koyama H; Tsukino M; Mishima M; Izumi T
Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369
[TBL] [Abstract][Full Text] [Related]
11. [Effect of ipratropium bromide on lung dynamic hyperinflation in patients with chronic obstructive lung disease].
Jorquera J; Díaz O; Lisboa C
Rev Med Chil; 2003 Jun; 131(6):605-12. PubMed ID: 12942587
[TBL] [Abstract][Full Text] [Related]
12. Acute bronchodilator therapy does not reduce wasted ventilation during exercise in COPD.
Elbehairy AF; Webb KA; Laveneziana P; Domnik NJ; Neder JA; O'Donnell DE;
Respir Physiol Neurobiol; 2018 Jun; 252-253():64-71. PubMed ID: 29578103
[TBL] [Abstract][Full Text] [Related]
13. [Effect of intravenous magnesium sulfate on chronic obstructive pulmonary disease exacerbations requiring hospitalization: a randomized placebo-controlled trial].
Abreu González J; Hernández García C; Abreu González P; Martín García C; Jiménez A
Arch Bronconeumol; 2006 Aug; 42(8):384-7. PubMed ID: 16948990
[TBL] [Abstract][Full Text] [Related]
14. Magnesium sulfate in exacerbations of chronic obstructive pulmonary disease.
Skorodin MS; Tenholder MF; Yetter B; Owen KA; Waller RF; Khandelwahl S; Maki K; Rohail T; D'Alfonso N
Arch Intern Med; 1995 Mar; 155(5):496-500. PubMed ID: 7864705
[TBL] [Abstract][Full Text] [Related]
15. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
Keam SJ; Keating GM
Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
[TBL] [Abstract][Full Text] [Related]
16. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease.
O'Donnell DE; Lam M; Webb KA
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1557-65. PubMed ID: 9817708
[TBL] [Abstract][Full Text] [Related]
17. Effect of fluticasone/salmeterol combination on dyspnea and respiratory mechanics in mild-to-moderate COPD.
Guenette JA; Webb KA; O'Donnell DE
Respir Med; 2013 May; 107(5):708-16. PubMed ID: 23421968
[TBL] [Abstract][Full Text] [Related]
18. Long-term effect of the beta2-receptor agonist procaterol on daily life performance and exercise capacity in patients with stable chronic obstructive pulmonary disease. Clinical study with special reference to health-related quality of life and activities of daily living.
Shioya T; Satake M; Sato K; Sano MA; Sugawara K; Takahashi H; Honma M
Arzneimittelforschung; 2008; 58(1):24-8. PubMed ID: 18368947
[TBL] [Abstract][Full Text] [Related]
19. Effects of inspiratory muscle training on dynamic hyperinflation in patients with COPD.
Petrovic M; Reiter M; Zipko H; Pohl W; Wanke T
Int J Chron Obstruct Pulmon Dis; 2012; 7():797-805. PubMed ID: 23233798
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
